Warm Greetings!!!

Welcome to yet another most pleasant Reading of our newsletter.

It is always my privilege to reach you on the 1st & 17th of every month, for the last 13 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.

Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief

"Legislations adopted in other progressive countries like Canada, the EU, the UK, Japan, Brazil, and Saudi Arabia, and the NITI Aayog Draft Medical Devices (Safety, Effectiveness and Innovation) Bill, 2019, could act as impactful works of reference to discipline manufacturers."

Prof. Bejon Kumar Misra International Consumer Policy Expert

August 2, 2023, The Centre is all set to revise its good practice guidelines for medium, small, and micro enterprises (MSMEs) engaged in making drugs after an inspection of scores of manufacturing sites and labs revealed glaring lapses. Read More... 

August 3, 2023, The scheme was announced in 2021 for 14 sectors such as telecommunication, white goods, textiles, manufacturing of medical devices, automobiles, speciality steel, food products, high-efficiency solar PV modules, advanced chemistry cell battery, drones and pharma with an outlay of Rs 1.97 lakh crore. Read More...

August 3, 2023, The central government has banned the manufacture, sale, and distribution of two veterinary drugs, Ketoprofen and Aceclofenac, citing risks to animal health and potential ecological damage, as per an official gazette notification issued on 1 August . Read More...

August 14, 2023, Asieris Pharmaceuticals, a global biopharma company, announced that the phase III bridging clinical trial of Hexvix for bladder cancer diagnosis met the primary endpoint. The results of the study will be submitted to the Chinese National Medical Products Administration (NMPA) for a new drug application (NDA) in the coming months. Read More...

August 9, 2023, The members attended the annual general body meeting of the Tamil Nadu Pharmaceutical Distributors Association (TNPDA) held in Tanjore on August 6 overwhelmingly agreed on a demand presented through a resolution by the organizing secretary that the drug manufacturing companies should stop direct supplies to the hospitals and market the products through proper channels. Read More...

August 14, 2023, In the wake of the margin issue raised recently by the Tamil Nadu Pharmaceutical Distributors Association (TNPDA), the Retail Distribution Chemists Alliance (RDAC) in Delhi, an affiliate of the All India Organisation of Chemists and Druggists (AIOCD), has demanded to the drug manufacturers to stop direct supply of medicines to private hospitals and clinics. It has also written to the drug manufacturers to display the names of their authorized stockists in each state on their websites. Read More...

August 12, 2023, Astellas Pharma US, Inc. announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) for Cresemba (isavuconazonium sulfate), a prodrug of isavuconazole, an azole antifungal drug, seeking approval for the treatment of invasive aspergillosis (IA) or invasive mucormycosis (IM) in paediatric patients aged one to 17 years old. Under the Prescription Drug User Fee Act (PDUFA), the FDA has set a target action date of December 9, 2023. Read More...

August 2, 2023, Mankind Pharma Ltd on Wednesday reported a 66% growth in profit for the first quarter of fiscal year 2024 on strong domestic sales. Its net profit rose to Rs 494 crore as compared to net profit of ₹298 crore in the corresponding quarter of 2022-23. Read More...

August 3, 2023, LICENSING is a dirty word in the common sense of contemporary economic policymaking. But, at the risk of inviting criticism from self-styled free-market champions, the government must introduce licensing for the export of drugs. India’s fair name as the pharmacy of the world is far too valuable to risk by letting market forces work freely in the area of supplying drugs to the world. Read More...

August 02, 2023, his acquisition is as per the Share Purchase Agreement signed and Public Announcement made on April 24, 2023 and the acquisition of the shares is completed today under block deal mechanism of The National Stock Exchange of India Ltd. (NSE). Read More...

August 02, 2023, The Jan Vishwas (Amendment of Provisions) Bill, 2022, recently passed in the Lok Sabha, decriminalises about 180 minor offences across 42 central laws spanning pharma, media, agriculture, the environment and industry. By converting or “compounding” prison sentences into fines and penalties, the new law will enable businesses to breathe freely. However, the recent debate around the Bill has centred around its amendments to the Drugs and Cosmetics Act, 1940. Read More...

The main issues which could come up for discussions in this round include an investment treaty, reduction of duties on auto and whiskey and matters about services, the official said

Press Trust of IndiaNew Delhi

As India and the UK are close to concluding negotiations for a proposed free trade agreement (FTA), chief negotiators of both countries will hold the 12th round of talks from August 7 here, an official said.

Both sides are looking at concluding the talks before the end of the year. Read More...

 August 14, 2023, Specially engineered Dehumidifiers are available today to meet the specific needs of the pharmaceutical industry, experts said adding that these dehumidifier come with new-generation desiccant technology that is adept at saving 30 per cent energy while giving an unmatched performance at 95°C temperature in pharmaceutical plants. Read More...

August 12, 2023, The National Institute of Mental Health and Neurosciences (NIMHANS) is accelerating its pace of human resources training to provide the much-needed convenient care. The institute sees the need to build a pool of clinical psychologists to widen the scope of therapy access. India a few years ago accounted for 1.5 clinical psychologist for 100,000 population which is now increased to 4.5 clinical psychologists catering to 100,000 population. Read More...

These include the drugs aspirin, ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve). Combination medications. Aspirin or acetaminophen (Tylenol, others) or both are often combined with caffeine or a sedative drug in a single medication

August 4, 2023, Scientists have found a naturally occurring strain of bacteria that can help stop the transmission of malaria from mosquitoes to humans.They found it by chance after a colony of mosquitoes in one experiment did not develop the malaria parasite  Read More...

August 11, 2023, Mumbai based Jaslok Hospital successfully performed minimally invasive spine surgery on a 99-year-old woman. The patient is the oldest in western India to have undergone the procedure and is now able to walk as a result of the surgery's success and multidisciplinary care at Jaslok Hospital. Read More...

Dr. Anamika Wadhera 

BDS, MPH, MSW, MWMA

Director

Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSAIIF may not be held responsible for any article published in The Prescription.